IDM Pharma (IDMI) Reports Q4 Loss of $0.07
IDM Pharma, Inc. (Nasdaq: IDMI) reports Q4 loss of $0.07, compared to a net loss of $0.11 in the same quarter last year. Revenue for the quarter was $300K, versus $5.6 million in Q407.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Mentor Graphics Corp (MENT) Beats Q1 EPS View by 5c; Lifts FY13 Outlook
- Synopsys, Inc. (SNPS) Misses Q2 EPS by 2c; Issues Confident Q3 Outlook; Guides FY12
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
